Literature DB >> 25840629

Survey of asthma management in Thailand - the asthma insight and management study.

Watchara Boonsawat1, Philip J Thompson, Uraiwan Zaeoui, Chanee Samosorn, Gurbet Acar, Rab Faruqi, Piriya Poonnoi.   

Abstract

BACKGROUND: Previous Thai surveys of asthma care have shown suboptimal management and poor control. Since then several editions of the Thailand National Asthma Guidelines have been distributed to help improve asthma control. A new survey was undertaken to see if any improvement in care had occurred. It examined patients' insights, attitudes and perceptions about their asthma and its treatment.
METHODS: Asthma patients (>12 years) were randomly selected and participated in face-to-face interviews. Patients answered 53 questions exploring general health, diagnosis, symptoms, exacerbations, patient burden, disease management, treatment and attitudes. The Global Initiative for Asthma guidelines were used to assess asthma control.
RESULTS: Data were obtained from 400 asthma patients from 8,177 screened households. This showed that 36% had had exacerbations in the previous year, 17% had been hospitalized and 35% had had an unscheduled emergency visit to hospital or a doctor's office or clinic. Work or school was missed by 44% due to asthma while a similar number had had an asthma episode that made them feel their life was in danger. Only 8% had good asthma control. Patients had low expectations with respect to asthma treatment and their understanding of how to use therapies was poor. Forty-four percent of participants reported day-time symptoms and about one-third (34%) of adults and adolescents in the survey reported night-time symptoms at least once a week in the previous 4 weeks. Asthma patients in Thailand rated their average productivity when asthma was at its worst at 48%, on a scale of 0 to 100%, which equates to a 36% decline in productivity. Rescue medication during the previous four weeks had been used by 44% of asthma patients while 54% had used a controller medication. Pill controller medication is the most used form among those reporting controller medication use (67%), whereas 57% reported taking an inhaler. Oral steroids had been used in the previous 12 months by 40% of patients with the average number for 3 day or longer at 24 times, while the median was about 4 times.
CONCLUSIONS: Asthma had a profound impact on patients' wellbeing, despite the availability of effective treatments and evidence-based management guidelines. A large proportion of asthma patients overestimate their asthma control and have inappropriate concepts about asthma treatment. Gaining better insight into patient's attitudes about self-care is critical to improve asthma management.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25840629     DOI: 10.12932/AP0473.33.1.2015

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  7 in total

1.  Nasal High-flow Oxygen Versus Conventional Oxygen Therapy for Acute Severe Asthma Patients: A Pilot Randomized Controlled Trial.

Authors:  Onlak Ruangsomboon; Chok Limsuwat; Nattakarn Praphruetkit; Apichaya Monsomboon; Tipa Chakorn
Journal:  Acad Emerg Med       Date:  2020-12-22       Impact factor: 3.451

2.  Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study.

Authors:  Kim Watkins; Michelle Trevenen; Kevin Murray; Peter A Kendall; Carl R Schneider; Rhonda Clifford
Journal:  BMJ Open       Date:  2016-08-31       Impact factor: 2.692

3.  Estimates of the Global Burden of Ambient [Formula: see text], Ozone, and [Formula: see text] on Asthma Incidence and Emergency Room Visits.

Authors:  Susan C Anenberg; Daven K Henze; Veronica Tinney; Patrick L Kinney; William Raich; Neal Fann; Chris S Malley; Henry Roman; Lok Lamsal; Bryan Duncan; Randall V Martin; Aaron van Donkelaar; Michael Brauer; Ruth Doherty; Jan Eiof Jonson; Yanko Davila; Kengo Sudo; Johan C I Kuylenstierna
Journal:  Environ Health Perspect       Date:  2018-10       Impact factor: 9.031

4.  Impact of asthma control on different age groups in five Latin American countries.

Authors:  Marcela Batan Alith; Mariana Rodrigues Gazzotti; Oliver Augusto Nascimento; José Roberto Jardim
Journal:  World Allergy Organ J       Date:  2020-04-01       Impact factor: 4.084

5.  Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population.

Authors:  Hironori Sagara; Nathalie Barbier; Tsuyoshi Ishii; Hajime Yoshisue; Ivan Nikolaev; Motoi Hosoe; Yasuhiro Gon
Journal:  BMJ Open Respir Res       Date:  2021-03

Review 6.  Perspectives on decisions for treatment and care in severe asthma.

Authors:  Tonya Winders; Jorge Maspero; Luke Callan; Mona Al-Ahmad
Journal:  World Allergy Organ J       Date:  2021-01-16       Impact factor: 4.084

7.  Health Effects of the Asthma Care Program under the Universal Coverage Scheme in Children and Young Adults in Thailand.

Authors:  Phatthanawilai Namuenhong Inmai; Tippawan Liabsuetrakul; Nao Ichihara; Hiroyuki Yamamoto; Jutatip Thungthong; Virasakdi Chongsuvivatwong; Hiroaki Miyata
Journal:  Int J Environ Res Public Health       Date:  2022-03-31       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.